The human 5-hydroxytryptamine 5-HT1A receptor gene was transfected into Chinese hamster ovary cells. A series of recombinant monoclonal cell lines expressing the receptor were isolated and the properties of one cell line that expressed receptors at a high level (2.8 pmol/mg) were studied in detail. In 
INTRODUCTION
5-Hydroxytryptamine (5-HT) is an important neurotransmitter in the brain and periphery which is involved in a variety of behavioural and physiological functions, including sleep, pain perception, control of mood, sexual behaviour and memory (Dourish, 1987) . Radioligand binding assays using a range of ligands have revealed a heterogeneous population of G-proteinlinked transmembrane 5-HT receptors comprising the 5-HT 1A' 5-HT 5-HTIC 5-HT 1D 5-HT 1E 5-HT2 and 5-HT4 subtypes (Dumuis et al, 1988; Leonhardt et al., 1989; Hibert et al., 1990) .
Of these, the 5-HTIA receptor is of interest because the new anxiolytic drug buspirone is active at this site, and buspirone seems to exhibit few of the side-effects of the benzodiazepine anxiolytics (Dourish, 1987) .
The gene sequences coding for the 5-HTLA, 5-HT C and receptors are now known (Kobilka et al., 1987; Fargin et al., 1988; Julius et al., 1988; Pritchett et al., 1988) , permitting structure-function studies to be carried out by site-directed mutagenesis and expression in animal cell lines. Expression of these receptors in cell lines also enables comparisons of the pharmacological profile of the various subtypes to be made in an environment free of cross-reacting sites. Furthermore, information about linkage to second messengers can be gained which is particularly desirable in the case of the 5-HTLA receptor, since this receptor has been reported to be linked to both stimulation and inhibition of adenylate cyclase activity (De Vivo & Maayani, 1986; Shenker et al., 1987) .
We report here the high-level expression of the human 5-HTlA receptor in Chinese hamster ovary (CHO) cells, the characterization of the ligand-binding properties of the receptor and its linkage via G-proteins to inhibition of adenylate cyclase.
MATERIALS AND METHODS

Transfection of S-HTIA receptor gene into CHO cells
The XbaI-BamHI fragment of the human genomic clone G21 (Fargin et al., 1988) , was excised from the plasmid pSP64-G21, which was kindly supplied by Dr. R. J. Lefkowitz, Duke University, Durham, NC, U.S.A., and purified by electrophoresis on low-melting-point agarose prior to ligation into the unique XbaI and BamHI cloning sites in the eukaryotic expression vector pSVL (Pharmacia Ltd.). Highly purified pSVL-G21 was obtained by two rounds of CsCl centrifugation.
CHO cells lacking dihydrofolate reductase (DHFR) activity (DHFR-) (Urlaub & Chasin, 1980) were grown in Dulbecco's modified Eagle's medium supplemented with hypoxanthine, thymidine, L-proline and 100% dialysed foetal bovine serum.
Cells were co-transfected with a 10:1 ratio of pSVL-G21 and an expression vector carrying the DHFR gene (pSV2-DHFR) (Urlaub & Chasin, 1980) by the calcium phosphate precipitation method (Page, 1988 ) using a total of 10,g of DNA/106 cells. Both pSVL-G21 and pSV2-DHFR had been linearized with the restriction enzyme PvuI.
Transfected cells stably expressing DHFR were selected by omission of hypoxanthine and thymidine from the growth medium. The medium was changed every 2 or 3 days until all the cells in a control untransfected flask with selective medium had died. Transfection efficiency was approx. 1 colony per 50000 cells. The mixed population of surviving transfectants was tested for expression of the 5-HTlA receptor by binding of a 6 nM concentration of the high-affinity 5-HTlA-specific agonist
[3H]8-OH-DPAT to the cell homogenate. Monoclonal cell lines were isolated by dilution cloning and 35 of these were screened for receptor expression. Clonal cell lines were routinely grown in adherent culture as described above, and except where otherwise stated all data were obtained using cells grown in adherent culture.
For growth of cells in suspension, 1.5 litres of medium (RPMI containing 10 % foetal bovine serum) was inoculated with 107 cells grown in adherent culture. The cell suspension was then gently stirred at 60 rev./min at 37°C in 5 % CO2. The cells were harvested when the cell density reached 106 cells/ml, usually after 6-7 days.
Northern blot analysis was carried out essentially according to the method of Sambrook et al. (1989) using as a probe the XbaI-BamHI fragment of the G21 sequence (Fargin et al., 1988) labelled with 32P by random priming. RNA was purified from control and recombinant CHO cells and separated by electrophoresis on a 1.5 % agarose gel containing formaldehyde. The RNA was then transferred to a nylon membrane (Genescreen) and baked for 2 h at 80°C. Hybridization was carried out overnight using 20 ng of the labelled probe/ml at 37°C in medium containing 4 x SSPE (1 x SSPE = 0.15 MNaCl/10 mM-NaH2PO4/l mM-EDTA, pH 7.4), 1 % SDS, 500,ug of salmon sperm DNA/ml, 250,ug of tRNA/ml and 50% formamide. Washing conditions for the final two 30 min washes were 0.1 x SSC/0.1I % SDS at 68°C (1 x SSC = 0.15M-NaCl/0.01 M-sodium citrate). The membrane was exposed to X-ray film for 24 h at -70°C with an intensifying screen.
Preparation of cell extracts
Cell homogenates were prepared by scraping the cells from the culture flasks with a rubber policeman, followed by Polytron homogenization at maximum speed for 10 s. For cells grown in suspension culture, cells were harvested by centrifugation (1700 g, 15 min, 4°C) and a homogenate was prepared as above. A crude cell membrane preparation was obtained by centrifugation of the cell homogenate at 300 g (10 min, 4°C), followed by centrifugation of the supernatant at 48 000 g (30 min, 4°C). The pellet was resuspended in assay buffer and stored at -80°C.
Bovine hippocampal membranes were prepared as described by Norman et al. (1985) , except that a Potter-S Teflon/glass homogenizer was used to disrupt the tissue (15 passes, 850 rev./min). The homogenate was centrifuged at 300 g (10 min, 4°C) before centrifugation of the supernatant twice at 48 OOOg (15 min, 4°C), the final pellet being resuspended in assay buffer and frozen at -80°C. Protein measurements were as described in Lowry et al. (1951 Fig. 3 ). The two receptors had very similar affinities for the compounds tested. In all cases, the competition data fitted best to single- Table 1. presence of GTP (Fig. 4) or guanosine 5'-[Vy-imido]triphosphate (Gpp[NH]p), which both showed very similar potencies. IC50 values for GTP were 6.9 + 2.7 ,UM (mean + S.E.M., n = 4, clone 7) and 11.6+2.3 ,UM (n = 4, hippocampus), and for Gpp[NH]p were 12.5 + 4.0 ,M (n = 3; clone 7) and 6.3 + 2.1 ,UM (n = 3, hippocampus).
To test the ability of the expressed receptor to produce an intracellular response in a second messenger system, adenylate cyclase activity was measured in homogenates of control and recombinant (clone 7) CHO cells with and without forskolin and 5-HT agonists (Fig. 5) . Whereas 100 1tM-forskolin stimulated adenylate cyclase [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] for membrane preparation, 7.5 + 2.8 aM, n = 4).
In contrast, for cells grown in suspension culture there was a gradual loss of the ability of 5-HT agonists to inhibit forskolinstimulated adenylate cyclase (Fig. 6) , with no inhibition observed after at least 25 days in suspension culture. This loss of inhibition was seen both as a decrease in the maximal inhibition achieved Table 3 . Characterization of 5-TL1A receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in clone 7 cells Adenylate cyclase activity was determined as in Table 2 . The 'effect ( %)' is the inhibition of forskolin-stimulated adenylate cyclase seen at high concentrations of the agonist, expressed as a percentage of the inhibition produced by high concentrations of 5-carboxamidotryptamine (39 ± 2 %, mean +s.E.M., n = 5, inhibition of the forskolin stimulation). Values are means+ S.E.M. of n determinations performed in triplicate.
IC50
Effect Ligand (clone 7) grown in adherent or suspension culture Adenylate cyclase activity (stimulated by 100,uM-forskolin) was determined as described in the Materials and methods section in the presence of different concentrations of 5-carboxamidotryptamine. The data are means of triplicate determinations and are for cells grown in adherent culture (A), or cells grown in suspension culture for 4 days (0), 5 days (El) and 25 days (A). The curves were obtained by non-linear regression using the computer program Genfit. IC50 values for 5-carboxamidotryptamine were 1.49 + 0.36 nM (mean + S.E.M., n = 5) for adherent cultured cells, and for cells grown in suspension culture they were 3.5 nM (n = 1; 4 days), 30.9 nM (n = 1; 5 days) and > 1000 nM (n = 3; 25 days). and in competition studies (Gozlan et al., 1983; Hall et al., 1985; Hoyer et al., 1985) . However, when the human 5-HTLA receptor was expressed stably in HeLa cells and the rat receptor was expressed in Ltk-cells, saturation analysis of [3H]8-OH-DPAT binding indicated two affinity states (Kd values respectively 0.4 nM/1.89 nM and 0.78 nM/8.7 nM; Fargin et al., 1989; Albert et al., 1990) . For other receptors, higher-and loweraffinity agonist binding sites have been attributed to interactions with G-proteins, with the higher-affinity binding sites being associated with receptors coupled to G-proteins and the loweraffinity binding sites associated with uncoupled receptors. In the present report, the expressed receptors in cells grown in adherent culture seemed to be in a single affinity state with high affinity for agonists. The coupling of this form to a G-protein is supported by the fact that essentially all the [3H]8-OH-DPAT binding could be eliminated by GTP or Gpp[NH]p. The IC50 values for the guanine nucleotides are very close to those found in bovine hippocampus (present study) and rat hippocampus (Hall et al., 1985) . These IC50 values are, however, substantially higher than values obtained with 5-HTLA receptors expressed in other cell lines (see above; Fargin et al., 1989; Albert et al., 1990) , suggesting that the coupling of receptor and G-protein may vary according to the cell type used for expressing the recombinant receptor.
The expressed 5-HTlA receptor in clone 7 cells was also functional in that 5-HT agonists inhibited forskolin-stimulated adenylate cyclase, and the effect of a 5-HT agonist could be inhibited by an antagonist, spiperone. The inhibition of adenylate cyclase by a 5-HT agonist could also be prevented by pretreatment of the cells with pertussis toxin, so that a Gi-or G0-type of G-protein must be involved. Although some studies in brain tissue report 5-HTlAreceptor inhibition of adenylate cyclase (De Vivo & Maayani, 1986) , in other studies stimulation of the enzyme is reported (Shenker et al., 1987) . In the present study there was no evidence for stimulation, and the stimulation in brain homogenate may therefore reflect activation of another 5-HT receptor closely related to the 5-HTlA receptor expressed here.
Three 5-HTlA receptor agonists (5 carboxamidotrypamine, 8-OH-DPAT and buspirone) with differing abilities to inhibit adenylate cyclase in brain (De Vivo & Maayani, 1986; Dumuis et al., 1987; Schoeffter & Hoyer, 1988) were tested on clone 7 cells in the present study. Each agonist was able to inhibit adenylate cyclase to different extents when used at a high concentration. Both the extent of the inhibition and the IC50 values for inhibition were comparable with data obtained for brain (De Vivo & Maayani, 1986; Dumuis et al., 1987; Schoeffter & Hoyer, 1988 of receptor protein in the future. However, although receptor number was maintained, the ability of the receptor to inhibit adenylate cyclase was gradually lost in suspension culture. This did not reflect a change in receptor-G-protein coupling, as judged by the ability of GTP to inhibit [3H]8-OH-DPAT binding. The most likely explanation seems to be a change at the level of the G-protein-adenylate cyclase interaction. This could in turn reflect effects on the cytoskeleton caused by the rather different requirements of cells for growth in suspension culture compared with adherent culture. Alternatively, the effects could result from an exhaustion of a factor in the culture medium which affects adenylate cyclase responses. For example, Johnson et al. (1990) have described effects of serum components on the activity of receptor-linked adenylate cyclase activities.
The cell line (clone 7) expressing human 5-HTlA receptors, analysed in detail here, provides a very useful model system for studying the receptor. It must be remembered that the cell line is an artificial system which may contain interactions not normally found in vivo, such as between the recombinant receptor and 'incorrect' G-proteins. Nevertheless, the ligand-binding properties of the receptor are essentially identical to those of the receptor expressed in brain, and the receptor is coupled via a Gprotein to a response typical ofthe 5-HTlA receptor, i.e. inhibition of adenylate cyclase. The level of receptor expression (approx. 3 pmol/mg of protein) is about seven times that of brain tissue, and the use of the CHO cell as the cell host for expression should enable large-scale suspension culture of the cell line to be carried out under well-defined conditions (e.g. see Curling et al., 1990) . This recombinant cell line should therefore provide a very useful system for studies on the 5-HTIA receptor protein, particularly for receptor isolation and purification.
